BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29626422)

  • 1. HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments.
    Farman GP; Rynkiewicz MJ; Orzechowski M; Lehman W; Moore JR
    Arch Biochem Biophys; 2018 Jun; 647():84-92. PubMed ID: 29626422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Cardiomyopathic Mutations in Tropomyosin on Calcium Regulation of the Actin-Myosin Interaction in Skeletal Muscle.
    Kopylova GV; Shchepkin DV; Borovkov DI; Matyushenko AM
    Bull Exp Biol Med; 2016 Nov; 162(1):42-44. PubMed ID: 27878731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M8R tropomyosin mutation disrupts actin binding and filament regulation: The beginning affects the middle and end.
    Racca AW; Rynkiewicz MJ; LaFave N; Ghosh A; Lehman W; Moore JR
    J Biol Chem; 2020 Dec; 295(50):17128-17137. PubMed ID: 33020181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the tropomyosin cardiomyopathy mutations on the calcium regulation of actin-myosin interaction in the atrium and ventricle differ.
    Kopylova GV; Berg VY; Kochurova AM; Matyushenko AM; Bershitsky SY; Shchepkin DV
    Biochem Biophys Res Commun; 2022 Jan; 588():29-33. PubMed ID: 34942531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies.
    Gupte TM; Haque F; Gangadharan B; Sunitha MS; Mukherjee S; Anandhan S; Rani DS; Mukundan N; Jambekar A; Thangaraj K; Sowdhamini R; Sommese RF; Nag S; Spudich JA; Mercer JA
    J Biol Chem; 2015 Mar; 290(11):7003-15. PubMed ID: 25548289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels.
    Kopylova GV; Shchepkin DV; Nabiev SR; Matyushenko AM; Koubassova NA; Levitsky DI; Bershitsky SY
    J Muscle Res Cell Motil; 2019 Dec; 40(3-4):299-308. PubMed ID: 31643006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
    Bing W; Knott A; Redwood C; Esposito G; Purcell I; Watkins H; Marston S
    J Mol Cell Cardiol; 2000 Aug; 32(8):1489-98. PubMed ID: 10900175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy Mutation Alters End-to-End Junction of Tropomyosin and Reduces Calcium Sensitivity.
    Sundar S; Rynkiewicz MJ; Ghosh A; Lehman W; Moore JR
    Biophys J; 2020 Jan; 118(2):303-312. PubMed ID: 31882250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments.
    Lehman W; Hatch V; Korman V; Rosol M; Thomas L; Maytum R; Geeves MA; Van Eyk JE; Tobacman LS; Craig R
    J Mol Biol; 2000 Sep; 302(3):593-606. PubMed ID: 10986121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate 139 of tropomyosin is critical for cardiac thin filament blocked-state stabilization.
    Barry ME; Rynkiewicz MJ; Pavadai E; Viana A; Lehman W; Moore JR
    J Mol Cell Cardiol; 2024 Mar; 188():30-37. PubMed ID: 38266978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
    Robinson P; Griffiths PJ; Watkins H; Redwood CS
    Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations Q93H and E97K in
    Śliwinska M; Robaszkiewicz K; Wasąg P; Moraczewska J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of muscle thin filament models obtained from electron microscopy reconstructions and low-angle X-ray fibre diagrams from non-overlap muscle.
    Poole KJ; Lorenz M; Evans G; Rosenbaum G; Pirani A; Craig R; Tobacman LS; Lehman W; Holmes KC
    J Struct Biol; 2006 Aug; 155(2):273-84. PubMed ID: 16793285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiomyopathy-linked mutations K15N and R21H in tropomyosin on thin-filament regulation and pointed-end dynamics.
    Ly T; Pappas CT; Johnson D; Schlecht W; Colpan M; Galkin VE; Gregorio CC; Dong WJ; Kostyukova AS
    Mol Biol Cell; 2019 Jan; 30(2):268-281. PubMed ID: 30462572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy landscapes reveal the myopathic effects of tropomyosin mutations.
    Orzechowski M; Fischer S; Moore JR; Lehman W; Farman GP
    Arch Biochem Biophys; 2014 Dec; 564():89-99. PubMed ID: 25241052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.
    Golitsina N; An Y; Greenfield NJ; Thierfelder L; Iizuka K; Seidman JG; Seidman CE; Lehrer SS; Hitchcock-DeGregori SE
    Biochemistry; 1997 Apr; 36(15):4637-42. PubMed ID: 9109674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
    Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
    Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.